Literature DB >> 10498138

Determinants of survival and length of survival in adults with Eisenmenger syndrome.

W J Cantor1, D A Harrison, J S Moussadji, M S Connelly, G D Webb, P Liu, P R McLaughlin, S C Siu.   

Abstract

A retrospective study of adults with Eisenmenger syndrome assessed at a tertiary referral center was performed to identify clinical characteristics and establish prognostic determinants. Mortality and cause of death are reported with baseline clinical data correlated with mortality to identify predictors of death. Clinical events during follow-up, including heart failure, atrial arrhythmia, hemoptysis, and syncope were also reviewed. A total of 109 adults with Eisenmenger syndrome (mean +/- SD age 29 +/- 11 years, 43% men) were followed for a median of 6.3 years. Sixty-six patients (61%) had simple cardiac anatomy (13 atrial septal defect, 43 ventricular septal defect, 10 patent ductus arteriosus). The remainder (43 patients) had complex cardiac anatomy (including atrioventricular septal defect, truncus arteriosus, univentricular heart, and transposition of the great arteries). There were 33 deaths and 9 transplantations during follow-up. Median survival was 53 years. Multivariate Cox regression analysis identified age at presentation (hazard ratio [HR] 0.90), supraventricular arrhythmia (HR 3.44), precordial electrocardiogram voltage (HR 1.61/mV increase), and poor New York Heart Association functional class (HR 2.60) as independent predictors of mortality. There is a large variation in the life expectancy for adults with Eisenmenger syndrome. Baseline characteristics associated with increased mortality include younger age at presentation (associated with complex anatomy), functional class, supraventricular arrhythmia, and an electrocardiogram index for right ventricular hypertrophy.

Entities:  

Mesh:

Year:  1999        PMID: 10498138     DOI: 10.1016/s0002-9149(99)00415-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  [Medical guideline for the treatment of adults with congenital heart abnormalities of the German-Austrian-Swiss Cardiology Specialty Society].

Authors:  A A Schmaltz; U Bauer; H Baumgartner; R Cesnjevar; F de Haan; C Franke; H Gabriel; C Gohlke-Bärwolf; S Hagl; J Hess; M Hofbeck; H Kaemmerer; H C Kallfelz; P E Lange; H Nock; E Oechslin; K R Schirmer; U Tebbe; P Trigo Trindade; M Weyand; G Breithardt
Journal:  Clin Res Cardiol       Date:  2008-03       Impact factor: 5.460

Review 2.  Pulmonary hypertension complicating congenital heart disease.

Authors:  J Eduardo Rame
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

Review 3.  Management of acute heart failure in adult patients with congenital heart disease.

Authors:  Alexander Van De Bruaene; Lukas Meier; Walter Droogne; Pieter De Meester; Els Troost; Marc Gewillig; Werner Budts
Journal:  Heart Fail Rev       Date:  2018-01       Impact factor: 4.214

4.  Epoprostenol treatment in children with severe pulmonary hypertension.

Authors:  Astrid E Lammers; Alison A Hislop; Yvette Flynn; Sheila G Haworth
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

5.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

6.  Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.

Authors:  Benjamin W Kelemen; Stephen C Mathai; Ryan J Tedford; Rachel L Damico; Cecilia Corona-Villalobos; Todd M Kolb; Neal F Chaisson; Traci Housten Harris; Stefan L Zimmerman; Ihab R Kamel; David A Kass; Paul M Hassoun
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

7.  First successful heart-lung transplantation in Japan: report of a case.

Authors:  Yoshiki Sawa; Goro Matsumiya; Shigefumi Shigemura; Hiroyuki Nishi; Hajime Ichikawa; Masato Minami; Norihide Fukushima; Masayoshi Inoue; Takayoshi Ueno; Akiyoshi Sawabatav; Taichi Sakaguchi; Shunsuke Saito; Meinoshin Okumura
Journal:  Surg Today       Date:  2013-02-20       Impact factor: 2.549

Review 8.  Arrhythmias in pulmonary arterial hypertension.

Authors:  Archana Rajdev; Hasan Garan; Angelo Biviano
Journal:  Prog Cardiovasc Dis       Date:  2012 Sep-Oct       Impact factor: 8.194

9.  Pulmonary hypertension in adult congenital heart disease.

Authors:  Josanna Rodriguez-Lopez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08

10.  Clinical implications of haemoptysis in patients with pulmonary arterial hypertension.

Authors:  Jose Cantu; Degang Wang; Zeenat Safdar
Journal:  Int J Clin Pract Suppl       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.